| Ticker Symbol: | AGN |
|---|---|
| Exchange: | NYSE |
| Contact Info: | 2525 Dupont Drive Irvine CA 92612 714 246-4500 |
| CEO/President: | David E.I. Pyott |
| Industry: | Medical - Drugs / Standard Industry Code: 2834 |
| Description: | Allergan, Inc. is a provider of eye care and specialty pharmaceutical products throughout the world with products in the eye care pharmaceutical, ophthalmic surgical device, over-the-counter contact lens care, movement disorder, and dermatological markets. Its worldwide consolidated revenues are principally generated by prescription and non-prescription pharmaceutical products in the areas of ophthalmology and skin care, neurotoxins, intraocular lenses and other ophthalmic surgical products, and contact lens care products. |
| Shares Outstanding: | 305,000 (000) | Market Value: | 12,643,660 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 92.52% | Number of Inst.Shareholders: | 0.00% |
| Last Quarter Sales: | 1172.00 ($Mil.) | Last Quarter Net Income: | 147.30 ($Mil.) |
| Last Quarter EPS: | 0.63 | P/E Ratio: | 18 |
| Most Recent Earnings: | 0.63 on 07/30/08 | Earnings Per Share: | 1.87 |
| Most Recent Split: | 2-1 on 06/25/07 | Annual Dividend Rate: | .2 |
| Most Recent Dividend: | 0.050 on 08/13/08 | Annual Dividend Yield: | .48% |


| PFIZER INC | -40.50 | 15.14 | |
| JOHNSON AND JOH | -19.70 | 55.85 | |
| MERCK CO INC | -54.70 | 26.23 | |
| BRISTOL MYERS S | -39.70 | 17.56 | |
| SCHERING PLOUGH | -58.90 | 13.36 |
